Outgrowth, long term self renewal and terminal maturation of human erythroid progenitors derived form umbilical cord blood in serum-free medium can be modulated by steroid hormones. Homogenous erythroid cultures, as characterized by flow cytometry and dependence on a specific mixture of physiological proliferation factors were obtained within 8 days from a starting population of mature and immature mononuclear cells. Due to previous results in mouse and chicken erythroblasts, the proliferation-promoting effect of glucocorticoids was not unexpected. Surprisingly, however, androgen had a positive effect on the sustained expansion of human female but not male erythroid progenitors. Under optimal conditions, sustained proliferation of erythroid progenitors resulted in a >10 9 -fold expansion within 60 days. Terminal erythroid maturation was significantly improved by adding human serum and thyroid hormone (T3) to the differentiation medium. This resulted in highly synchronous differentiation of the cells towards enucleated erythrocytes within 6 days, accompanied by massive size decrease and hemoglobin accumulation to levels comparable to those in peripheral blood erythrocytes. Thus, obviously, different, ligand-activated nuclear hormone receptors massively influence the decision between self renewal and terminal maturation in the human erythroid compartment.
Introduction
Hematopoietic development within the erythroid lineage requires a delicate balance between the opposing effects of proliferation-promoting factors maintaining the renewal capacity of immature erythroid progenitors, and differentiation-inducing factors required for successful terminal maturation of erythroid progenitors into red blood cells 1 . In adult humans, erythroid differentiation produces about 2x10 11 (roughly 20g) red cells per day, representing the most vigorous proliferation process in the entire body. Since low numbers of erythrocytes are immediately life-threatening, erythropoiesis needs regulatory mechanisms temporarily altering the balance towards enhanced proliferation, to cope with stress situations such as low oxygen levels at elevated altitudes (hypoxia) or massive blood loss.
In vivo, both renewal and maturation of human erythroid progenitors proceed in parallel in the bone marrow. It has thus been difficult to assess the contribution of particular signaling pathways and their deregulation during aberrant depletion of these progenitors, or their death upon differentiation in anemia, versus unscheduled progenitor proliferation (as occurring in leukemogenesis). Most information was obtained from established cell lines and -more recently-primary animal cell models of chicken and mouse in defined media [1] [2] [3] . The latter approach even allowed to analyze cells from genetically modified mice [4] [5] [6] . For sustained proliferation, both, avian and murine primary erythroblasts require co-operation between erythropoietin (Epo), stem cell factor (SCF) and glucocorticoids (dexamethasone; Dex).
Involvement of Epo and SCF was expected from their contribution to proliferation/survival of erythroid cells [7] [8] [9] , whereas the stress hormone Dex massively prolonged progenitor proliferation (from 10 to 30 days in chicken, 7 to 20 days in mouse), at the same time reducing their rate of spontaneous differentiation. Our idea that this might point to specific roles for glucocorticoids in stress erythropoiesis could be verified in vivo using mutant mice carrying a dimerization-defective glucocorticoidreceptor (GR-dim). In contrast to wild-type mice, GR-dim mice could not respond to hypoxia or experimental anemia with increased erythroblast renewal 10 .
Interestingly, activated leukemia oncogenes utilize the same signaling pathways driving transient renewal during stress erythropoiesis to induce permanent proliferation as well as differentiation arrest in leukemia. The v-ErbB oncogene product of avian erythroblastosis virus (AEV) or endogenous mouse c-ErbB can substitute for ligand activation of EpoR plus c-Kit, the SCF receptor 11, 12 .
On the other
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These observations indicated a need for corresponding studies in human erythroblasts under in vivo-like conditions. Although cooperation between Epo, SCF and Dex was shown to induce renewal of human erythroblasts 14 , the use of serumcontaining media limited the usefulness of these culture conditions with respect to cell numbers and homogeneity of cells obtained. Human erythroid cell lines such as K562, yielding unlimited cell numbers, are even less useful, since they proliferate in the absence of physiological regulators and thus compromise mechanistic studies.
Finally, techniques to expand erythroid progenitors from multipotent ones in two-or three-step protocols 15 yield cell populations which undergo sustained proliferation for <2 weeks, accompanied by high rates of spontaneous differentiation. Thus, contributions of individual exogenous factors to self renewal versus maturation were difficult to assess by these approaches.
We addressed this problem by systematically exploring the renewal-and differentiation requirements of erythroid progenitors from umbilical cord blood. Cord blood has received a lot of attention as a source for hematopoietic stem cells (mainly CD34+) as an alternative to bone marrow stem cells in transplantation medicine [16] [17] [18] [19] .
Furthermore, cord blood is a source of multipotent stem cells, which may replace human ES cells in future forms of therapy 20 Schärfe-System, Reutlingen, Germany); cumulative cell numbers were calculated as described 22 . Proliferating erythroid progenitors could be frozen and thawed with high efficiency (>90%).
Differentiation induction
To induce terminal differentiation, proliferating erythroblasts were washed in ice-cold PBS and re-seeded at 2x10 6 cells/mL in StemSpan TM supplemented with Epo (10U/mL), insulin (Ins; 4x10 -4 IE = 10ng/mL, Actrapid HM, Bagsvaerd, Denmark), the Dex antagonist ZK112993 (3µM) 23 , iron-saturated human transferrin (1mg/mL; Sigma), and 3% human male serum (Sigma). Differentiating erythroblasts were maintained at 2-4x10 6 cells/mL by daily cell counts and partial medium changes.
Cell morphology, histological staining and hemoglobin determination
Erythroblasts at various differentiation stages were cytocentrifuged onto glass slides and stained with histological dyes and benzidine for hemoglobin as described 24 . To
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Apoptosis assay
Cells (2x10 6 ) were fixed in 0,5mL 8% para-formaldehyde in PBS for 30min at room temperature and stored in 70% ethanol at -20°C. Cells were washed in PBS and incubated in 45µl labeling-plus 5µl enzyme solution (fluorescein-dUTP; TdT; In situ Cell Death Detection Kit, Roche) for 1h at 37°C. Cells were washed once, resuspended in PBS and subjected to flow cytometry to determine percentages of TUNEL positive cells.
Flow cytometry
Erythroblasts (1x10 DNA profiles were determined in a PAS-III flow cytometer (Partec, Germany)
after staining cellular DNA with 6µM 4,6-diamidino-2-phenylindole-dihydrochloride (DAPI). Percentages of cells in specific cell cycle phases were calculated using a software package of the same manufacturer 26 . 
Density gradient purification of hematopoietic cells

Results
In vitro mass culture of human erythroid progenitors from umbilical cord blood Human erythroid progenitors were expanded from umbilical cord blood after selective lysis of mature erythrocytes (Material and Methods) in serum-free medium (StemSpan TM ) by using a combination of Epo, SCF, Dex (synthetic glucocorticoid) and IGF1, some of which are typical for stress erythropoiesis 10 (Table 1A) . From day 3 on, a small population of expanding erythroid progenitors became visible in cytospins, which was clearly detectable in an electronic cell analyzer (CASY) around day 6 as an increasing population of large, non-adherent cells (~12µm diameter; In experiments to further improve the medium composition (Table 1A) To verify that the cultures remained dependent on each of the proliferation factors required for erythroid progenitor expansion and/or survival during the entire expansion period, cell batches pre-grown for 18 days in complete medium were switched to media lacking either single or all factors. The requirement for Epo, SCF and/or Dex was then assessed by measuring cell numbers ( Figure 3A ) and rates of apoptosis by TUNEL assays (Material and Methods; Figure 3B ). In our hands, omission of IGF-1 did not decrease proliferation rates within 8 days, consistent with findings in murine erythroblasts 12 . Since, however, IGF-1 was previously reported several times to support long-term survival of myeloid progenitors 28, 29 as well as committed erythroid cells 7, 30 , the media used in further experiments were nevertheless supplemented with IGF1.
As expected, erythroblasts exposed to medium without factors stopped proliferating within 24 to 48 hours. After 2 days, more than 75% and after 4 days essentially all cells had died from apoptosis ( Figure 3B ). Glucocorticoid receptor signaling (GR) was abolished by removal of Dex plus addition of the glucocorticoid antagonist ZK 23 . Under these conditions, cells rapidly ceased to proliferate; >50% were apoptotic after two days, confirming the strict requirement for this hormone for renewal 14 . Omitting Dex from the medium alone caused only partial effects, in line with findings in several nuclear receptors including GR that antagonist is required to enforce an inactive receptor conformation and releasing receptor-bound ligand 31, 32 .
The glucocorticoid levels present In serum-containing media make it difficult or impossible to observe Dex effects 33, 34 . However, addition of the ZK antagonist showed that human erythroblasts require Dex also for expansion in serum-containing media 14 . In the absence of Epo or SCF all progenitors disintegrated within 6 days, but proliferation arrest and apoptosis were delayed in the absence of Epo as compared to SCF, similar to previous findings in chicken and mouse 12, 35 . Taken together, cultured human erythroblasts remain strictly dependent on Epo, SCF and Dex throughout their extended period of exponential proliferation. 
Androgen enhances proliferation of female but not male human erythroblasts
Due to their predominantly gender-specific actions, the potential of sexual steroids to modulate human hematopoietic development in vitro has not been addressed so far. However, disturbances in sex steroids contribute to a number of diseases such as anemia 40 . In chicken, estrogen and glucocorticoid receptor ligands (Dex) both contribute to long-term self renewal of erythroid progenitors 41, 42 andconsequently-interfere with terminal maturation 43 .
These observations prompted us to expand human erythroblasts in the presence of various other hormones besides Dex. While estrogen and progesterone had no effects (Table 1A) , dihydro-testosterone (an androgen) significantly enhanced the proliferation rate of cells from certain cord blood donors but not from others. One way to interpret this puzzling behavior was that androgen might act in a genderspecific manner. Thus, erythroid progenitors from cord blood of male and female newborns were expanded in the presence or absence of dihydro-testosterone. As a control, the androgen antagonist cyproterone-acetate (Cpa) 44 was included ( Figure 5 ; see also Supplementary Figure 2' ).
Dihydro-testosterone had no effect on the proliferation of "male" cells over 25 days of culture. However, for "female" erythroblasts a significant and reproducible enhancement in proliferation was observed with dihydro-testosterone. The antagonist Cpa reduced the testosterone-induced, increased proliferation of female cultures back to the level of untreated controls but not below, while again it had no effect on male cultures ( Figure 5 ). This indicates that the androgen effect was specific and
Induction of synchronous terminal differentiation
Most established erythroid cell lines to study terminal erythroid differentiation suffer from drawbacks like un-physiological stimuli required to initiate maturation, asynchronous progress into differentiation, low levels of hemoglobin synthesized and a failure to enucleate. Recently, we established conditions for efficient terminal maturation of primary and permanently proliferating (p53-deficient) mouse Differentiation media consisted of serum-free medium (StemSpan TM ) used for expansion plus factors/hormones to be tested (Table 1B) .
To follow the progress of terminal maturation, proliferation rate, volume decrease (measured in a cell analyzer) and hemoglobin accumulation (quantitative photometric assay, see 25 and Materials and Methods) were monitored daily. In addition, cyto-centrifugation followed by histological staining was applied for phenotypic characterization, again to assess hemoglobinization but also to detect enucleated erythrocytes at the end of maturation. Differentiation with the factor mix used for mouse cells did not yield satisfying results. Rather than differentiating, the cells underwent apoptosis at high frequency and accumulated little hemoglobin ( Figure 6A -E). Systematic variation of multiple differentiation medium components to improve terminal maturation of immature progenitors was ineffective (Table 1B) . In contrast, addition of normal human serum combined with Epo high /Ins was found to strongly improve synchronous differentiation.
Like chicken and mouse erythroblasts 3, 45 , human erythroid progenitors continued to divide upon differentiation initiation but only for 1-2 divisions, as compared to 4-5 in chicken and 3-4 in mouse ( Figure 6A ). Accompanying these "differentiation divisions", cell size decreased from about 660 to 380fl. Hemoglobin accumulation started from very low levels ( Figure 6C ,E) -confirming the low rate of spontaneous differentiation in the renewing cells-and steadily increased more than 10-fold within 6 days. Hemoglobin levels reached ~35% (11.5±1.0pg; n=5) of the value determined for peripheral human erythrocytes (31.6±2.4pg; n=5). Although
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Terminal erythropoiesis was also assessed on the basis of the cell surface markers c-Kit (CD117; characteristic for proliferating erythroid progenitors), transferrin receptor (CD71) and glycophorin A (GPA, both markers for mature cells).
As expected, erythroblasts differentiating in the presence of serum showed a downregulation of c-Kit to background levels and a further induction of GPA (from 70% to 100% positive cells; Figure 6F ). CD71 expression at the cell surface was human serum factor(s) for terminal differentiation, which is not required in mouse cells, pointing to an apparent difference between murine and human erythropoiesis.
Thyroid hormone (T3) improves terminal maturation of human erythroblasts
One possibility to explain the above serum effects could be that human and murine erythroid cells differ in their responsiveness to thyroid hormone (T3). Since lack of T3 in humans is associated with anemia 47, 48 and its addition strongly accelerates terminal differentiation of chicken erythroblasts 13, 49 , we analyzed the effect of T3 on human erythroid differentiation, together with several other hormones (Table 1B) . Like for serum, this T3 effect raised the question, whether the hormone would shift the balance between proliferation and differentiation, as previously observed in chicken erythroblasts 49 . Indeed, addition of T3 under proliferation conditions increased the proportion of spontaneous differentiation, as judged from reduced proliferation rates, gradual decrease of cell size and detectable amounts of hemoglobin synthesized (Supplementary Figure 4' ). . In both chicken and mouse erythroblasts, ligand-activated GR cooperates with activated Epo receptor (EpoR) and c-Kit, the stem cell factor (SCF) receptor to retain erythroid cells in an immature state and thus to induce long-term proliferation 12, 42, 53, 54 . A similar effect of glucocorticoids was described in human erythroblasts 14 , but their expansion was limited to 15-22 cell divisions, probably due to the use of serum-containing media. Importantly, GR is also required for stress erythropoiesis following hypoxia or blood loss in the mouse 10 .
In our hands, the serum-free medium (StemSpan™) employed here was critical for generating long-term cultures. Other serum-free media proved less efficient, the specific type of human serum albumin contained in this medium being one likely candidate. The inclusion of even small amounts of serum (human, calf) strongly increased the rate of spontaneous differentiation 34, 55 . Given our results on the differentiation-promoting effects of thyroid hormone and numerous reports on [56] [57] [58] , it may well be that the absence of these serum components from the synthetic StemSpan™-medium was critical for achieving long term proliferation of erythroid progenitors. Comparing to other current procedures, it should also be noted that our conditions did not require positive pre-selection for immature, pluri-potent progenitors (e.g. CD34+/c-Kit-) 55, 59 , negative selection 62, 63 . There is some biochemical evidence for the expression of androgen receptor (AR) in erythroblasts from human bone marrow cultures 64 and megakaryocytes 65 . Given the major role of GR in these cells, one might speculate about a cross-talk between AR and GR, similarly to the cross-talk described between estrogen receptor and progesterone receptor 66 or TGFalpha receptor (cErbB) 41 . Similar to inhibition of the PR-ER cross-talk with estrogen antagonists, liver GR activity could be inhibited with cyproterone acetate 67 . At present, we cannot explain the gender-specificity of proliferation enhancement by androgen. No differences in GR potency/expression levels between males and females have been reported. Also, promiscuity for the corresponding hormone . In addition, females receiving dihydro-testosterone therapy also show higher hematocrits 75, 76 , which was already noted decades ago in breast cancer patients receiving androgen for therapeutic reasons 77, 78 . To our knowledge, however, there were so far no data on female-restricted proliferationpromoting effects of androgen in erythroid cells in vitro, which should facilitate molecular evaluation of the pathways involved.
Also the direct, differentiation promoting effect of thyroid hormones (in particular 3,5,3'-tri-iod-L-thyronin, T3) on human erythroid progenitors merits further mechanistic exploration. Although thyroids are required for normal development, differentiation and metabolism of many cell types 79, 80 , little is known about their role in normal erythropoiesis. In mice lacking TRalpha, TRbeta or both, standard hematopoiesis appears unaffected [81] [82] [83] . Primary chicken erythroblasts overexpressing TRalpha variants (gag-cErbA) in the absence of T3 underwent sustained proliferation in co-operation with liganded c-Kit 13 . In contrast, T3 accelerated differentiation of normal avian erythroid progenitors and even promoted differentiation under proliferation conditions 49, 84 . Thus, in this avian model, TRalpha appeared as a ligand-operated "switch", modulating the balance between renewal and differentiation 13 . So far we could not reproduce these results in the mouse (HB, unpublished). It was thus interesting to find clear evidence for a function of T3 in human erythroid progenitor maturation, operating efficiently at the endogenous TR without requiring over-expression.
Our data, show profound effects of steroids and thyroids on renewal, proliferation and differentiation of long-term proliferating, immature human erythroid progenitors, leading to several additional considerations. On the medical side, it may
For personal use only. on August 16, 2017 . by guest www.bloodjournal.org From be worthwhile to (re)evaluate and eventually adjust the hormone status in some forms of (mild) anemia, e.g. in post-menopausal women, which although not lifethreatening are reducing quality of life. The protocol for cell expansion reported here can also be applied to cells from peripheral blood: In preliminary tests, we not only expanded erythroid progenitors but also cells of other hematopoietic lineages in factor combinations used for multipotent progenitors (C. Leberbauer, D. Genz; in preparation). With respect to molecular mechanisms, our cells are ideal for expression profiling approaches, aimed at identifying target genes specifically modulated in their expression by the hormones used in this study.
Taken together, the advances in long-term expansion of hematopoietic (erythroid) cells described here can facilitate extensive biochemical analyses of cells from patients with hereditary hematopoietic disorders (e.g. thalassemias), which were technically demanding so far due to lack of material. Our system will also be ideal to address novel pathways modulating the balance between renewal and erythroid maturation in vitro. Table 1A ). Cell volume changes were monitored with an electronic cell analyzer. Right panels: At the times indicated, cells were cytocentrifuged onto glass slides and stained with cytological dyes. During the first few days, multiple cell types like leukocytes, macrophages and only few erythroblasts are present, the proportion of which increases upon culture in specific erythroid factors (Epo, Dex, mSCF and IGF1). At day 10, the majority of cells in the rapidly proliferating cultures (mitoses indicated by arrows) show an erythroblast morphology. Table 1A ). 
